Author Title [ Type(Desc)] Year
Filters: Author is Lerman, Lilach O  [Clear All Filters]
Journal Article
Pawar, A.S., Eirin, A., Krier, J.D., Woollard, J.R., Zhu, X.-Y., Lerman, A., van Wijnen, A.J., and Lerman, L.O. (2019). Alterations in genetic and protein content of swine adipose tissue-derived mesenchymal stem cells in the metabolic syndrome.Stem Cell Res37, 101423.
Eirin, A., Zhu, X.-Y., Puranik, A.S., Woollard, J.R., Tang, H., Dasari, S., Lerman, A., van Wijnen, A.J., and Lerman, L.O. (2016). Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells.Sci Rep6, 36120.
Zhu, X.-Y., Lerman, A., and Lerman, L.O. (2013). Concise Review: Mesenchymal Stem Cell Treatment for Ischemic Kidney Disease.Stem Cells.
Eirin, A., Zhu, X.-Y., Ebrahimi, B., Krier, J.D., Riester, S.M., van Wijnen, A.J., Lerman, A., and Lerman, L.O. (2014). Intra-renal delivery of mesenchymal stem cells and endothelial progenitor cells attenuates hypertensive cardiomyopathy in experimental renovascular hypertension.Cell Transplant.
Eirin, A., and Lerman, L.O. (2014). Mesenchymal stem cell treatment for chronic renal failure.Stem Cell Res Ther5, 83.
Ebrahimi, B., Eirin, A., Li, Z., Zhu, X.-Y., Zhang, X., Lerman, A., Textor, S.C., and Lerman, L.O. (2013). Mesenchymal Stem Cells Improve Medullary Inflammation and Fibrosis after Revascularization of Swine Atherosclerotic Renal Artery Stenosis.Plos One8, e67474.
Nargesi, A.Aghajani, Zhu, X.-Y., Hickson, L.T.J., Conley, S.M., van Wijnen, A.J., Lerman, L.O., and Eirin, A. (2018). Metabolic Syndrome Modulates Protein Import into the Mitochondria of Porcine Mesenchymal Stem Cells.Stem Cell Rev.
Eirin, A., Riester, S.M., Zhu, X.-Y., Tang, H., Evans, J.M., O'Brien, D., van Wijnen, A.J., and Lerman, L.O. (2014). MicroRNA and mRNA Cargo of Extracellular Vesicles from Porcine Adipose Tissue-Derived Mesenchymal Stem Cells.Gene.
Prasad, M., Corban, M.T., Henry, T.D., Dietz, A.B., Lerman, L.O., and Lerman, A. (2020). Promise of Autologous CD34+ Stem/Progenitor Cell Therapy for Treatment of Cardiovascular Disease.Cardiovasc Res.
Hickson, L.T.J., Prata, L.G.P.Langhi, Bobart, S.A., Evans, T.K., Giorgadze, N., Hashmi, S.K., Herrmann, S.M., Jensen, M.D., Jia, Q., Jordan, K.L., et al. (2019). Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.Ebiomedicine.